Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion type Assertion NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_head.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion description "[As a result, the IC50 values of 24 anticancer drugs obtained from the brain cancer cells clearly showed patient cell-specific efficacy, some of which were well-correlated with their oncogene overexpression (c-Met and FGFR1) as well as the in vivo previous results of the mouse xenograft model with the three primary brain cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_provenance.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion evidence source_evidence_literature NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_provenance.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion SIO_000772 24199994 NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_provenance.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion wasDerivedFrom befree-20150227 NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_provenance.
- NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_assertion wasGeneratedBy ECO_0000203 NP400687.RAQhG9z4VbzjPe0Q6b6BQcTJgPE6WZSff3tRQTj27EETU130_provenance.